Comparison of the effectiveness and complications of Desferal and Desphonac in thalassemic patients

Phase 2

Recruiting

• Conditions: Thalassemia.; Beta thalassemia

• Registration Number: IRCT20130812014333N117
• Lead Sponsor: Kermanshah University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 25 March 2019

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 98

Inclusion Criteria

Patients with intermedia and major thalassemia

Exclusion Criteria

Renal patients
Patients with hypertension, skin diseases, liver complications, and respiratory and auditory diseases

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Respiratory status. Timepoint: Beginning of the study and end of the study (three months later). Method of measurement: According to clinical symptoms and asking patients.;Digestive complications. Timepoint: Beginning of the study and end of the study (three months later). Method of measurement: According to symptoms and asking patients.;Skin complications. Timepoint: Beginning of the study and end of the study (three months later). Method of measurement: According to clinical symptoms and asking patients.;Renal and hepatic complications. Timepoint: Beginning of the study and end of the study (three months later). Method of measurement: blood test.